Thursday, November 27, 2014 3:35:23 PM
WavePOD Prototype Fit for European Tryouts
193___Selected
Carnegie Wave Energy’s collaborative project to develop a standardised, self-contained offshore electricity generator for the wave industry has moved a step closer last week when a tenth-scale WavePOD prototype moved to the Institute for Fluid Power Drives and Controls (IFAS) at Aachen University, Germany.
The WavePOD wave power offtake device is being developed by global drive and control manufacturer Bosch Rexroth as part of a collaboration including some of Europe’s leading wave energy developers, utilities and academic institutions including Carnegie’s 100% UK subsidiary, CETO Wave Energy UK. The project’s goal is to develop an industry-wide power take off that will generate electricity reliably and cost effectively at sea.
The laboratory testing at Aachen University’s world-class facility is designed to provide performance data on the WavePOD unit to allow Bosch Rexroth to develop and refine the prototype prior to in-ocean testing. In-ocean testing is initially planned for fellow wave developer, Aquamarine Power’s Oyster 800 device in Scotland and subsequently targeted for Carnegie Wave Power’s CETO technology at WaveHub in Cornwall.
The tenth scale prototype, which weighs ten tonnes and comprises a drive train, cylinder frame and power take off, has been manufactured in Middlesbrough and at Bosch Rexroth’s hydraulics centre at St Neots, Cambridgeshire, prior to being shipped to IFAS.
The WavePOD prototype development and testing programme receives funding support from the Scottish Government’s Marine Renewables Commercialisation Fund (MRCF). The collaboration brings together with European industrials Bosch Rexroth and Irish utility ESB, along with Aquamarine Power, Carnegie’s UK subsidiary, CWE UK, Albatern and Manchester University spin-off M4M. ESB is also developing the European-funded Westwave wave project off the west coast of Ireland.
Press Release, September 23, 2014
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM